165 related articles for article (PubMed ID: 8864548)
1. Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation.
Teixeira MM; Rossi AG; Giembycz MA; Hellewell PG
Br J Pharmacol; 1996 Aug; 118(8):2099-106. PubMed ID: 8864548
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
[TBL] [Abstract][Full Text] [Related]
3. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
[TBL] [Abstract][Full Text] [Related]
5. Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo.
Teixeira MM; Hellewell PG
Eur J Pharmacol; 1997 Apr; 323(2-3):255-60. PubMed ID: 9128847
[TBL] [Abstract][Full Text] [Related]
6. Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils.
Kaneko T; Alvarez R; Ueki IF; Nadel JA
Cell Signal; 1995 Jul; 7(5):527-34. PubMed ID: 8562314
[TBL] [Abstract][Full Text] [Related]
7. Adhesion mechanisms involved in C5a-induced eosinophil homotypic aggregation.
Teixeira MM; Rossi AG; Hellewell PG
J Leukoc Biol; 1996 Mar; 59(3):389-96. PubMed ID: 8604017
[TBL] [Abstract][Full Text] [Related]
8. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.
Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA
Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the inhibitory activity of selective PDE4 inhibitors on eosinophil recruitment in guinea pig skin.
Teixeira MM; Miotla JM; Cooper N; Gristwood RW; Hellewell PG
Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():193-6. PubMed ID: 9698932
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
Hatzelmann A; Tenor H; Schudt C
Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
[TBL] [Abstract][Full Text] [Related]
11. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D
Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060
[TBL] [Abstract][Full Text] [Related]
12. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol.
Au BT; Teixeira MM; Collins PD; Williams TJ
Br J Pharmacol; 1998 Mar; 123(6):1260-6. PubMed ID: 9559913
[TBL] [Abstract][Full Text] [Related]
13. Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.
Dent G; Giembycz MA; Evans PM; Rabe KF; Barnes PJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1167-74. PubMed ID: 7996422
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram.
Underwood DC; Osborn RR; Novak LB; Matthews JK; Newsholme SJ; Undem BJ; Hand JM; Torphy TJ
J Pharmacol Exp Ther; 1993 Jul; 266(1):306-13. PubMed ID: 8392555
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.
Cohan VL; Showell HJ; Fisher DA; Pazoles CJ; Watson JW; Turner CR; Cheng JB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1356-61. PubMed ID: 8819523
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.
Raeburn D; Underwood SL; Lewis SA; Woodman VR; Battram CH; Tomkinson A; Sharma S; Jordan R; Souness JE; Webber SE
Br J Pharmacol; 1994 Dec; 113(4):1423-31. PubMed ID: 7889300
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
Blease K; Burke-Gaffney A; Hellewell PG
Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
[TBL] [Abstract][Full Text] [Related]
18. Desensitization of beta2-adrenoceptor and hypersensitization to phosphodiesterase inhibitors elicited by beta2-agonists in guinea pig eosinophils.
Mio M; Kirino Y; Kamei C
J Allergy Clin Immunol; 2000 Nov; 106(5):896-903. PubMed ID: 11080712
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.
Cooper N; Teixeira MM; Warneck J; Miotla JM; Wills RE; Macari DM; Gristwood RW; Hellewell PG
Br J Pharmacol; 1999 Apr; 126(8):1863-71. PubMed ID: 10372831
[TBL] [Abstract][Full Text] [Related]
20. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
